WALTHAM, Mass., Feb. 26, 2016 -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will discuss AMAG’s business and financial outlook, strategy and growth prospects at the following investor conferences taking place in March 2016.
- Cowen and Company 36th Annual Health Care Conference
Presentation: Monday, March 7, 2016 at 2:00 p.m. ET*
One-on-one meetings: Monday, March 7, 2016
Location: Boston, MA - Raymond James & Associates’ 37th Annual Institutional Investors Conference
Presentation: Tuesday, March 8, 2016 at 11:00 a.m. ET*
One-on-one meetings: Tuesday, March 8, 2016
Location: Orlando, FL - Barclays Global Healthcare Conference
Fireside chat: Wednesday, March 16, 2016 at 3:50 p.m. ET*
One-on-one meetings: Wednesday, March 16, 2016
Location: Miami, FL
*A live webcast of the presentation will be accessible through the Investors section of the company’s website at www.amagpharma.com, and will be archived for 30 days.
About AMAG
AMAG Pharmaceuticals uses its expertise to develop and commercialize products that provide clear benefits and improve people’s lives. Based in Waltham, MA, AMAG has a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care. AMAG continues to work to expand the impact of these and future products for patients by delivering on its growth strategy, which includes organic growth, as well as the pursuit of products and companies that align with AMAG’s existing therapeutic areas or those that could benefit from its proven core competencies. For additional company information, please visit www.amagpharma.com.
AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals Contact: Maryann Cimino Manager, Corporate Communications & External Affairs 617-498-3375


Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
BP Nears $10 Billion Castrol Stake Sale to Stonepeak 



